Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published the
complete 2023 GOLD report, which can be freely downloaded from its web page (www …
complete 2023 GOLD report, which can be freely downloaded from its web page (www …
Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
K Miyashita, H Hozumi, K Furuhashi… - Emerging Microbes & …, 2023 - Taylor & Francis
ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic has dramatically changed
because of virus mutations, vaccine dissemination, treatment development and policies …
because of virus mutations, vaccine dissemination, treatment development and policies …
[HTML][HTML] The association between inhaled corticosteroid and the risks of SARS-COV-2 infection: A systematic review and meta-analysis
CH Chen, CY Chen, CC Lai, YH Wang… - Journal of Infection and …, 2023 - Elsevier
Background The effect of inhaled corticosteroid (ICS) on the risk of severe acute respiratory
syndrome coronavirus 2 (SARS-COV-2) infection is unclear. Methods We performed a …
syndrome coronavirus 2 (SARS-COV-2) infection is unclear. Methods We performed a …
Gold 2023: Highlights for primary care
A Agustí, A Sisó-Almirall, M Roman… - NPJ primary care …, 2023 - nature.com
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has issued its 2023
annual report 1. Compared with former versions, it has been significantly updated. Here, we …
annual report 1. Compared with former versions, it has been significantly updated. Here, we …
Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV …
WC Kwok, MF Tsoi, SHI Leung, CK Tsui, TCC Tam… - Viruses, 2023 - mdpi.com
While molnupiravir (MOV) and nirmatrelvir–ritonavir (NMV-r) were developed for treatment of
mild to moderate COVID-19 infection, there has been a lack of data on the efficacy among …
mild to moderate COVID-19 infection, there has been a lack of data on the efficacy among …
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive …
Objectives This study assessed the effectiveness of the oral antiviral agents nirmatrelvir–
ritonavir (NMV-r) and molnupiravir (MOV) for treating mild-to-moderate coronavirus disease …
ritonavir (NMV-r) and molnupiravir (MOV) for treating mild-to-moderate coronavirus disease …
Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 …
Aims We examined diabetes status (no diabetes; type 1 diabetes [T1D]; type 2 diabetes
[T2D]) and other demographic and clinical factors as correlates of coronavirus disease 2019 …
[T2D]) and other demographic and clinical factors as correlates of coronavirus disease 2019 …
Efficacy of mRNA and inactivated whole virus vaccines against COVID-19 in patients with chronic respiratory diseases
WC Kwok, SHI Leung, TCC Tam, JCM Ho… - … Journal of Chronic …, 2023 - Taylor & Francis
Background While different COVID-19 vaccines have been developed, there has been lack
of data on the efficacy comparison between mRNA and inactivated whole virus vaccine …
of data on the efficacy comparison between mRNA and inactivated whole virus vaccine …
[HTML][HTML] Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution
DV Parums - … Science Monitor: International Medical Journal of …, 2023 - ncbi.nlm.nih.gov
Abstract The 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report
includes relevant topics from the clinician's perspective and evidence published on chronic …
includes relevant topics from the clinician's perspective and evidence published on chronic …
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults
Objectives To determine whether acute exacerbations of chronic obstructive pulmonary
disease (AECOPD) triggered by severe acute respiratory syndrome coronavirus 2 (SARS …
disease (AECOPD) triggered by severe acute respiratory syndrome coronavirus 2 (SARS …